| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.34B | — | -2.2% |
| Cost of Revenue | $1.87B | — | -2.3% |
| Gross Profit | $468.0M | — | -1.7% |
| R&D Expense | $28.0M | — | -9.7% |
| SG&A Expense | $226.0M | — | -1.7% |
| Operating Income | $214.0M | — | +27.4% |
| Interest Expense | $183.0M | — | +7.6% |
| Pre-tax Income | $82.0M | — | +2833.3% |
| Income Tax | $33.0M | — | +266.7% |
| Net Income | $44.0M | — | +309.5% |
| EPS (Basic) | $0.40 | — | +310.5% |
| EPS (Diluted) | $0.40 | — | +310.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $1.10B | +19.0% | -11.5% |
| Inventory | $2.28B | +2.9% | -1.1% |
| Current Assets | $5.97B | +4.8% | +10.2% |
| Total Assets | $21.73B | +0.2% | -6.3% |
| Current Liabilities | $4.32B | +17.2% | +54.3% |
| Long-term Debt | $12.60B | -0.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $76.0M | — | +105.4% |
| Capital Expenditures | $66.0M | — | -35.3% |
| Investing Cash Flow | $425.0M | — | +533.7% |
| Financing Cash Flow | -$3.0M | — | -106.7% |
| Free Cash Flow | $10.0M | — | +115.4% |
| +0.3% |
| Stockholders' Equity | $4.06B | +0.3% | -21.7% |